The general purpose of PRECISEU is connecting innovation ecosystems across Europe to efficiently advance towards a trulypersonalised healthcare, transferring practices and solutions from region to region and scaling up deep-tech healthcare innovationsbased on advanced therapies medicinal products and health data across Europe.
The PRECISEU consortium...
SYNTHIA is an ambitious collaboration between public and private institutions to facilitate the responsible use of Synthetic Data (SD)in healthcare applications. The project will improve the methodological and technical aspects of SD Generation (SDG) by developingnew techniques and advancing established ones for different data modalities, including genomics and imaging, to...
VICT3R aims to significantly reduce the number of animals used in experimental studies performed during the nonclinical drug andchemical safety evaluation by replacing the animals of the concurrent controls groups (CCGs) with Virtual Control Groups (VCGs). These VCGs will be generated by means of state-of-the-art statistical or artificial intelligence (AI) approaches that...
The COVID pandemic can be seen as an experiment conducted on the entirety of humankind (as almost everybody has been or will get infected with SARS-CoV-2). It will therefore have the best coverage over the widest variation possible and is therefore ideally suited to study the effects of infections with SARS-CoV-2 on large quantities of heterogeneous individuals.